178 related articles for article (PubMed ID: 10207094)
1. Transcription factor E2F-1 is upregulated in response to DNA damage in a manner analogous to that of p53.
Blattner C; Sparks A; Lane D
Mol Cell Biol; 1999 May; 19(5):3704-13. PubMed ID: 10207094
[TBL] [Abstract][Full Text] [Related]
2. Antisense therapy targeting MDM2 oncogene in prostate cancer: Effects on proliferation, apoptosis, multiple gene expression, and chemotherapy.
Zhang Z; Li M; Wang H; Agrawal S; Zhang R
Proc Natl Acad Sci U S A; 2003 Sep; 100(20):11636-41. PubMed ID: 13130078
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the mdm2 oncogene by thyroid hormone receptor.
Qi JS; Yuan Y; Desai-Yajnik V; Samuels HH
Mol Cell Biol; 1999 Jan; 19(1):864-72. PubMed ID: 9858609
[TBL] [Abstract][Full Text] [Related]
4. Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14(ARF) tumor suppressor.
Dimri GP; Itahana K; Acosta M; Campisi J
Mol Cell Biol; 2000 Jan; 20(1):273-85. PubMed ID: 10594030
[TBL] [Abstract][Full Text] [Related]
5. The naturally occurring mutants of DDB are impaired in stimulating nuclear import of the p125 subunit and E2F1-activated transcription.
Shiyanov P; Hayes SA; Donepudi M; Nichols AF; Linn S; Slagle BL; Raychaudhuri P
Mol Cell Biol; 1999 Jul; 19(7):4935-43. PubMed ID: 10373543
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Mdm2-directed degradation by the C terminus of p53.
Kubbutat MH; Ludwig RL; Ashcroft M; Vousden KH
Mol Cell Biol; 1998 Oct; 18(10):5690-8. PubMed ID: 9742086
[TBL] [Abstract][Full Text] [Related]
7. Integrins regulate the apoptotic response to DNA damage through modulation of p53.
Lewis JM; Truong TN; Schwartz MA
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3627-32. PubMed ID: 11904424
[TBL] [Abstract][Full Text] [Related]
8. Molecular and Biochemical Techniques for Deciphering p53-MDM2 Regulatory Mechanisms.
Karakostis K; López I; Peña-Balderas AM; Fåhareus R; Olivares-Illana V
Biomolecules; 2020 Dec; 11(1):. PubMed ID: 33396576
[TBL] [Abstract][Full Text] [Related]
9. E2F-1 regulation by an unusual DNA damage-responsive DP partner subunit.
Ingram L; Munro S; Coutts AS; La Thangue NB
Cell Death Differ; 2011 Jan; 18(1):122-32. PubMed ID: 20559320
[TBL] [Abstract][Full Text] [Related]
10. Shaping the regulation of the p53 mRNA tumour suppressor: the co-evolution of genetic signatures.
Karakostis K; Fåhraeus R
BMC Cancer; 2019 Sep; 19(1):915. PubMed ID: 31519161
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene.
Raycroft L; Wu HY; Lozano G
Science; 1990 Aug; 249(4972):1049-51. PubMed ID: 2144364
[TBL] [Abstract][Full Text] [Related]
12. Expanding Roles of the E2F-RB-p53 Pathway in Tumor Suppression.
Zhou Y; Nakajima R; Shirasawa M; Fikriyanti M; Zhao L; Iwanaga R; Bradford AP; Kurayoshi K; Araki K; Ohtani K
Biology (Basel); 2023 Dec; 12(12):. PubMed ID: 38132337
[TBL] [Abstract][Full Text] [Related]
13. A Protein in the Yeast
Farooqi K; Ghazvini M; Pride LD; Mazzella L; White D; Pramanik A; Bargonetti J; Moore CW
Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32156076
[No Abstract] [Full Text] [Related]
14. E2F-dependent transcription determines replication capacity and S phase length.
Pennycook BR; Vesela E; Peripolli S; Singh T; Barr AR; Bertoli C; de Bruin RAM
Nat Commun; 2020 Jul; 11(1):3503. PubMed ID: 32665547
[TBL] [Abstract][Full Text] [Related]
15. DDB2 and MDM2 genes are promising markers for radiation diagnosis and estimation of radiation dose independent of trauma and burns.
Cai LH; Chen XY; Qian W; Liu CC; Yuan LJ; Zhang L; Nie C; Liu Z; Li Y; Li T; Liu MH
Funct Integr Genomics; 2023 Sep; 23(4):294. PubMed ID: 37688632
[TBL] [Abstract][Full Text] [Related]
16. A Cell-Penetrant Peptide Disrupting the Transcription Factor CP2c Complexes Induces Cancer-Specific Synthetic Lethality.
Son SH; Kim MY; Choi S; Kim JS; Lee YS; Lee S; Lee YJ; Lee JY; Lee SE; Lim YS; Ha DH; Oh E; Won YB; Ji CJ; Park MA; Kim B; Byun KT; Chung MS; Jeong J; Choi D; Baek EJ; Cho EH; Kim SB; Je AR; Kweon HS; Park HS; Park D; Bae JS; Jang SJ; Yun CO; Chae JH; Lee JW; Lee SJ; Kim CG; Kang HC; Uversky VN; Kim CG
Adv Sci (Weinh); 2023 Nov; 10(33):e2305096. PubMed ID: 37845006
[TBL] [Abstract][Full Text] [Related]
17. Protein neddylation and its role in health and diseases.
Zhang S; Yu Q; Li Z; Zhao Y; Sun Y
Signal Transduct Target Ther; 2024 Apr; 9(1):85. PubMed ID: 38575611
[TBL] [Abstract][Full Text] [Related]
18. Genomic and transcriptomic profiling reveal molecular characteristics of parathyroid carcinoma.
Jo SY; Hong N; Lee S; Jeong JJ; Won J; Park J; Kim GJ; Kim SK; Kim S; Rhee Y
Exp Mol Med; 2023 May; 55(5):886-897. PubMed ID: 37121965
[TBL] [Abstract][Full Text] [Related]
19. Pathway-based approach reveals differential sensitivity to E2F1 inhibition in glioblastoma.
Alvarado AG; Tessema K; Muthukrishnan SD; Sober M; Kawaguchi R; Laks DR; Bhaduri A; Swarup V; Nathanson DA; Geschwind DH; Goldman SA; Kornblum HI
Cancer Res Commun; 2022 Sep; 2(9):1049-1060. PubMed ID: 36213002
[TBL] [Abstract][Full Text] [Related]
20. Benzo[a]pyrene represses DNA repair through altered E2F1/E2F4 function marking an early event in DNA damage-induced cellular senescence.
Allmann S; Mayer L; Olma J; Kaina B; Hofmann TG; Tomicic MT; Christmann M
Nucleic Acids Res; 2020 Dec; 48(21):12085-12101. PubMed ID: 33166399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
